Two Sigma Investments’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-131,400
| Closed | -$3.54M | – | 3324 |
|
|
2022
Q4 | $3.54M | Buy |
131,400
+102,374
| +353% | +$2.69M | 0.01% | 1029 |
|
|
2022
Q3 | $521K | Buy |
+29,026
| New | +$463K | ﹤0.01% | 1759 |
|
|
2022
Q2 | – | Sell |
-17,022
| Closed | -$227K | – | 3104 |
|
|
2022
Q1 | $227K | Buy |
+17,022
| New | +$228K | ﹤0.01% | 2305 |
|
|
2021
Q4 | – | Sell |
-45,136
| Closed | -$1.01M | – | 5081 |
|
|
2021
Q3 | $1.01M | Buy |
+45,136
| New | +$991K | ﹤0.01% | 2608 |
|
|
2021
Q2 | – | Sell |
-36,997
| Closed | -$761K | – | 4728 |
|
|
2021
Q1 | $761K | Buy |
36,997
+10,329
| +39% | +$235K | ﹤0.01% | 2565 |
|
|
2020
Q4 | $737K | Buy |
26,668
+2,852
| +12% | +$55.5K | ﹤0.01% | 2220 |
|
|
2020
Q3 | $335K | Sell |
23,816
-131,450
| -85% | -$2.45M | ﹤0.01% | 2517 |
|
|
2020
Q2 | $3.2M | Sell |
155,266
-53,710
| -26% | -$731K | 0.02% | 865 |
|
|
2020
Q1 | $1.58M | Buy |
208,976
+151,633
| +264% | +$1.7M | 0.01% | 1107 |
|
|
2019
Q4 | $890K | Sell |
57,343
-10,130
| -15% | -$102K | ﹤0.01% | 2294 |
|
|
2019
Q3 | $351K | Buy |
67,473
+7,473
| +12% | +$55.4K | ﹤0.01% | 2837 |
|
|
2019
Q2 | $543K | Buy |
+60,000
| New | +$895K | ﹤0.01% | 2437 |
|
|
2018
Q4 | – | Sell |
-7,593
| Closed | -$202K | – | 3665 |
|
|
2018
Q3 | $202K | Buy |
+7,593
| New | +$172K | ﹤0.01% | 3011 |
|
Other funds holding MYOV
Two Sigma Investments's MYOV Position: Q1 2023 in Review
Two Sigma Investments sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 131,400 shares — an estimated $3.54M sold.
Two Sigma Investments first reported a position in MYOV in Q3 2018 and held it in 13 quarters. The position peaked at $3.54M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Two Sigma Investments reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Two Sigma Investments sold 131,400 Myovant Sciences Ltd. shares in Q1 2023, an estimated $3.54M.
- Two Sigma Investments first reported a position in Myovant Sciences Ltd. in Q3 2018 and held it in 13 quarters.
- Two Sigma Investments's Myovant Sciences Ltd. position peaked at $3.54M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.